124 related articles for article (PubMed ID: 38244685)
21. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
Albers EAC; de Ruiter MB; van de Poll-Franse LV; Merckel LG; Compter A; Schagen SB
J Neurooncol; 2022 Dec; 160(3):649-658. PubMed ID: 36454373
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
23. Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly.
Rades D; Nguyen T; Blanck O; Schild SE
In Vivo; 2020; 34(4):1909-1913. PubMed ID: 32606162
[TBL] [Abstract][Full Text] [Related]
24. Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic Radiosurgery and Radiotherapy: a Long Term Experience in Thailand.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Swangsilpa T; Vitoonpanich P; Yongvithisatid P
Asian Pac J Cancer Prev; 2015; 16(13):5279-84. PubMed ID: 26225666
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age.
Watanabe S; Yamamoto M; Sato Y; Kawabe T; Higuchi Y; Kasuya H; Yamamoto T; Matsumura A; Barfod BE
J Neurosurg; 2014 Nov; 121(5):1148-57. PubMed ID: 25061863
[TBL] [Abstract][Full Text] [Related]
26. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
[No Abstract] [Full Text] [Related]
28. To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy.
Babic S; Lee Y; Ruschin M; Lochray F; Lightstone A; Atenafu E; Phan N; Mainprize T; Tsao M; Soliman H; Sahgal A
J Appl Clin Med Phys; 2018 Mar; 19(2):111-120. PubMed ID: 29363282
[TBL] [Abstract][Full Text] [Related]
29. Single-centre experience of stereotactic radiosurgery and fractionated stereotactic radiotherapy for prolactinomas with the linear accelerator.
Wilson PJ; Williams JR; Smee RI
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):371-8. PubMed ID: 25410143
[TBL] [Abstract][Full Text] [Related]
30. Impact of collimator leaf width on stereotactic radiosurgery and 3D conformal radiotherapy treatment plans.
Kubo HD; Wilder RB; Pappas CT
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):937-45. PubMed ID: 10386653
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
32. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
33. Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.
Huber PE; Hawighorst H; Fuss M; van Kaick G; Wannenmacher MF; Debus J
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1339-49. PubMed ID: 11286842
[TBL] [Abstract][Full Text] [Related]
34. First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases.
Alongi F; Fiorentino A; Gregucci F; Corradini S; Giaj-Levra N; Romano L; Rigo M; Ricchetti F; Beltramello A; Lunardi G; Mazzola R; Ruggieri R
J Cancer Res Clin Oncol; 2019 Jan; 145(1):193-200. PubMed ID: 30382369
[TBL] [Abstract][Full Text] [Related]
35. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
36. Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience.
Kelly PJ; Lin YB; Yu AY; Ropper AE; Nguyen PL; Marcus KJ; Hacker FL; Weiss SE
J Neurooncol; 2011 Sep; 104(2):553-7. PubMed ID: 21213018
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
Cho KH; Hall WA; Lo SS; Dusenbery KE
Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
[TBL] [Abstract][Full Text] [Related]
38. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study.
Fiorentino A; Tebano U; Sicignano G; Ricchetti F; Di Paola G; Aiello D; Giaj-Levra N; Mazzola R; Fersino S; Ruggieri R; Alongi F
Phys Med; 2018 May; 49():135-138. PubMed ID: 28951047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
